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ABSTRACT The relationship between the structure and function of a series of nicotinic cholinergic agonists has been studied using
radioligand binding, single channel recording, and nuclear magnetic resonance spectroscopy. The cyclic compound 1,1 -dimethyl-4-ace-
tylpiperazinium iodide and its trifluoromethyl analogue (F3-PIP) interact with nicotinic acetylcholine receptors (nAChRs) from both
Torpedo electroplaque and BC3H-1 cells at lower concentrations than the acyclic derivatives, N,N,N,N'-tetramethyl-N'-acetylethylenedia-
mine iodide and its fluorinated analogue (F3-TED). The magnitude of the difference in potencies depends on the type of measurement. In
binding experiments, the differences between the two classes of compounds depends mainly on the conditions of the experiment. In
measurements of the initial interaction with the nAChR, the PIP compounds have an affinity approximately one order of magnitude higher
than that of the TED compounds. Longer incubations indicated that the PIP compounds were able to induce a time-dependent shift in
receptor affinity consistent with desensitization, whereas the TED compounds were unable to induce such a shift. The activation of single
channel currents by the cyclic compounds occurs at concentrations approximately two orders of magnitude lower than for the acyclic
compounds, but the TED compounds exhibit a larger degree of channel blockade than the PIP compounds. Previous work (McGroddy,
K. A., and R. E. Oswald. 1992. Biophys. J. 64:314-324) has shown that the TED compounds can exist in two energetically distinct
conformational states related by an isomerization of the amide bond. '9F nuclear magnetic resonance experiments suggest that the
higher energy population of the TED compounds may interact preferentially with the ACh binding sites on the nAChRs and that a
significant fraction of the difference between the initial affinity of the PIP and TED compounds may be accounted for by the predomi-
nance in solution of a conformational state less able to interact with the ACh binding sites on nAChRs.
INTRODUCTION
The cloning and sequencing of a large number of nico-
tinic acetylcholine receptor (nAChR)' subunits in re-
cent years has led to a wealth of information concerning
the specific amino acids thought to play important roles
in the acetylcholine binding sites and the binding sites
for channel blockers (for review, see Changeux, 1990).
Both site-directed mutagenesis (e.g., Galzi et al., 1991;
Tomaselli et al., 1991 ) and affinity labeling (e.g., Kao et
al., 1984; Galzi et al., 1990) have identified specific aro-
matic amino acids that may comprise part ofthe cholin-
ergic binding site in much the same way as the aromatic
residues found in the active site of acetylcholinesterase
(Sussman et al., 1991). Likewise, chemical modifica-
tions of agonist structure have been used to study the
important structural and electronic features required for
nicotinic cholinergic agonist activity (e.g., Papke et al.,
1988; Spivak et al., 1989). The original work of Beers
and Reich ( 1970) suggests that the requirements include
a positive charge distribution centered - 5.9 A from a
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dide; HTED, N,N,N,N'-tetramethyl-N'-acetylethylene-diamine iodide;
MOPS, 3-[N-morpholino]propanesulfonic acid; nAChR, nicotinic
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hydrogen bond acceptor. In addition, the presence of a
methyl group adjacent to the carbon atom bearing the
hydrogen bond acceptor is important (Waters et al.,
1988).
A commonly used approach to determine features im-
portant for binding involves the synthesis ofcompounds
with slight variations in their chemical structure (for re-
view, see Hansch, 1983). Comparison of the functional
effects of newly synthesized compounds with structures
obtained from either molecular modeling studies or nu-
clear magnetic resonance (NMR) spectroscopy may not
lead to clear results, however, since the structures being
studied in these cases may not resemble the bound state
structure ofthe ligand (e.g., Behling et al., 1988; Ni et al.,
1990). Also, in some cases, modifications of the chemi-
cal structure ofa ligand can produce unexpected changes
in its orientation within a binding site such that ligand
affinity is changed in an unpredictable fashion (Ealick et
al., 1991 ). Nevertheless, useful information has been ob-
tained by this approach when the chemical structures are
relatively rigid.
Two series of compounds that interact with nAChRs
were synthesized, one that is sterically restrained by the
presence of a piperazinium ring and the other that is
acyclic and presumably able to access a greater variety of
conformational states. The corresponding compounds
in each series are chemically identical except for the pres-
ence or absence of one C- C bond. Within the series of
cyclic compounds, the relationship between chemical
structure and biological activity is reasonably well de-
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fined (Carter et al., 1992). In this communication, we
attempt to compare the functional activity with the
structure of the cyclic versus acyclic compounds. Pre-
vious work (McGroddy and Oswald, 1992) has shown
that the cyclic 1,l-dimethyl-4-trifluoroacetylpiperazin-
ium iodide (PIP) compounds exist in two symmetric
solution state structures on the NMR time scale, both of
which undergo rapid chair/boat interconversion. The
acyclic N,N,N,N'-tetramethyl-N'-trifluoroacetylethylene-
diamine iodide (TED) compounds exist in two different
solution structures, one ofwhich is favored by -1 kcal/
mol over the other. The interconversion between these
two structures involves isomerization about an amide
bond and is characterized by a high energy barrier (- 19
kcal/mol) and an extremely slow rate constant at room
temperature (k -0.01 s-'). Radioligand binding and
single channel recording studies were used to investigate
the ability of these compounds to bind to and activate
the nAChR from Torpedo electric organ and from
BC3H-1 cells under several conditions. In addition, we
show using fluorine ('9F)NMR spectroscopy that one of
the two TED conformers can interact with the nAChR
from Torpedo electroplaque. No binding of the other
conformer was detected, although the presence of a
tightly bound species cannot be definitively ruled out.
These results suggest that the solution structure of the
TED compounds could play an important role in deter-
mining the binding affinity and, as will be discussed, can
provide suggestions as to the bound conformation ofthe
compound.
MATERIALS AND METHODS
Materials
Deuterium oxide was purchased from Aldrich Chemical Co. (Milwau-
kee, WI) at 99.9% purity. a[ '25I]Bungarotoxin (a[ '25I]Bgt; 70-140
Ci/mmol) was purchased from New England Nuclear (Wilmington,
DE). Frozen Torpedo nobiliana electroplaque was obtained from Bio-
fish Associates (Georgetown, MA). The BC3H-1 cell line was from
American Type Culture Collection (Rockville, MD). 1, 1-Dimethyl-4-
acetylpiperazinium iodide (HPIP), F3-PIP, N,N,N,N'-tetramethyl-N'-
acetylethylene-diamine iodide (HTED), and F3-TED were synthesized
as described previously (McGroddy and Oswald, 1992). a-Bungaro-
toxin (aBgt) was purified from the venom ofBungarus multicinctus as
described previously (Freeman et al., 1980), except that Mono Q and
Superose 12 columns were used in a Pharmacia (Gaithersburg, MD)
FPLC. The remaining chemicals were from Sigma Chemical Co. (St.
Louis, MO). Because of the slow hydrolysis in solution (t1/2 of -2 h,
measured by "9F and 'H NMR spectroscopy), F3-PIP was dissolved
immediately before use, and experiments using this compound were
completed within 25 min or less. F3-TED shows no sign of hydrolysis
for up to 12 h in solution under the conditions used in these experi-
ments.
Membrane preparation and cell culture
Torpedo electroplaque
Membranes rich in nAChRs were prepared from frozen Torpedo nobi-
liana as described previously (Saitoh et al., 1980) and were stored in
liquid nitrogen at 10-15 gM (expressed in aBgt binding sites) until
needed. The concentration of a[ 1251I]Bgt sites was measured by the
DE8 1 filter disc assay (Schmidt and Raftery, 1973) using 0.1% w/v
Triton X-100 in 10 mM tris(hydroxymethyl)-aminomethane (pH
7.2) as the buffer. The protein content of samples or bovine serum
albumin standards were determined using a Bicinchoninic acid Protein
Assay Kit from Pierce (Rockford, IL).
BC3H-1 cells
BC3H- 1 cells were grown and maintained in Dulbecco's modified Eagle
medium with 10% fetal calf serum at 37°C in 10% CO2 and passed
weekly. After enzymatic dissociation ofthe stock cultures, an aliquot of
the cells was resuspended in growth medium and plated in T-150
flasks. Twenty-four hours later, the cells were rinsed in low serum me-
dium (0.5% fetal calf serum) and subsequently maintained in low
serum medium with medium changes every 4-5 d (Olsen et al., 1983).
Cells were used for single channel recording or harvested for binding
assays 8-10 d after serum change. To harvest the cells, 20 ml per flask
of 20 mM 3-[N-morpholino]propanesulfonic N acid (MOPS)-NaOH
with 1 mM EGTA (pH 7.4) were added to the cells for 30 min at 4°C.
The cells were then collected in the same buffer and homogenized three
times in a Brinkman (Westbury, NY) Polytron (setting 6) for 10 s
each. The homogenate was centrifuged at 20,000 g for 30 min, and the
pellet was resuspended to 0.4 mg protein/ml in 50 mM MOPS-NaOH
with 1 mM EGTA (pH 7.5). This homogenate was used for subsequent
experiments.
Binding Measurements
The inhibition ofthe initial rate ofa[ '25I ] Bgt binding by HPIP, F3-PIP,
HTED, and F3-TED was measured in membrane fragments from both
Torpedo electroplaque and BC3H- 1 cells at 4°C. Two protocols were
used: simultaneous addition and prior addition. In both cases, the
buffer was 50 mM MOPS-NaOH with 5 mM EGTA (pH 7.5). The
a[ 1251]Bgt concentration was 5 nM for both tissue types. Torpedo
membranes were diluted to 2.5 nM (expressed in a[ 1251I] Bgt sites), and
BC3H- I membranes were used at a final dilution of0.2 mg protein/ml.
The simultaneous addition protocol consisted of mixing the PIP or
TED derivative with a[ 1251] Bgt and then adding this mixture to the
membrane fragments. This provides an indication of the ability of the
compound to inhibit a[ 1251 ] Bgt binding before the completion of the
slow phase ofdesensitization (Weber et al., 1975; Weiland et al., 1976).
The prior addition protocol consists of incubating the PIP or TED
derivatives with membrane fragments for 5-15 min, followed by the
addition of a[ '251 ] Bgt. This provides an indication of the ability ofthe
compound to bind to and desensitize the nAChR. The protection con-
stant (Kp) was determined for each data set by a nonlinear least-squares
fit (Marquardt-Levenberg algorithm; PLOT, Gradient Software, Inc.,
Ithaca, NY) to the following equation:
kT
_
1 + Kp
(1)
where L is the ligand concentration, nH is the Hill coefficient, and k'T
and kT are the initial rates of a['251]Bgt binding in the presence and
absence of competing ligand. In all cases, nH was not significantly dif-
ferent from 1, so that nH was fixed to a value of 1 in all subsequent
analyses. All computations were performed on a Sun (Mountain View,
CA) 4/330 workstation.
Single channel recording
Single channels were recorded from nAChRs on BC3H- 1 cells using the
cell attached configuration with the agonist in the pipette as described
by Hamill et al. (1981). Both the bathing medium and the medium
inside the pipette consisted of 147 mM NaCl, 5.4 mM KCI, 1 mM
MgCl2, and 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic
acid, pH 7.4. All data were collected using a Dagan patch clamp ampli-
326 Biophysical Journal Volume 64 February 1993Biophysical Journal Volume 64 February 1993
fier at 90 mV hyperpolarized with respect to resting potential, with the
temperature maintained at 15 ± 0.3°C using a Medical Systems
(Greenvale, NY) TC-202 temperature controller. The data were fil-
tered at 5 kHz using an 8 pole Bessel filter (Frequency Devices, Haver-
hill, MA) and transferred at 44kHz to a Macintosh Ilci computer. The
data were then transferred to a VAXStation II computer (Digital
Equipment Corp., Maynard, MA) for analysis. Semiautomated chan-
nel detection software with a threshold crossing algorithm and with
user-verification of all channels was used (software developed in the
laboratory).
Data analysis was performed on a Sun 4/330 or a Silicon Graphics
(Mountain View, CA) 4D/220 GTX workstation using software devel-
oped in the laboratory, except where otherwise indicated. Dwell times
were fit to multiple exponentials using maximum likelihood analysis
(Colquhoun and Sigworth, 1983) and a Simplex algorithm (Caceci and
Cacheris, 1984). Rate constants were estimated using three proce-
dures: (a) at low agonist concentrations where relatively simple corre-
lations between rate constants and exponential components of a dwell
time distribution could be made, the rates were estimated from the
presumed exponential components (exponential fitting); (b) data were
fit by comparing the predicted pdf for a given set of rate constants
(determined using the techniques described by Colquhoun and
Hawkes, 1981 ) with the observed data, and the constants were opti-
mized using a Simplex algorithm and the maximum likelihood crite-
rion (matrix method); and (c) rate constants were determined by com-
binatorial analysis as described by Horn and Lange ( 1983) using soft-
ware generously provided by Dr. Anthony Auerbach (which includes
subroutines provided by Dr. R. Horn). Two-dimensional dwell time
distributions (Magleby and Weiss, 1990) were displayed using Trans-
form and Format (Spyglass, Champaign, IL) on a Macintosh II com-
puter.
NMR experiments
Sample preparation
For the NMR samples, Torpedo membranes were thawed and incu-
bated with I mM diisopropyl fluorophosphate for 15 min to inactivate
residual acetylcholinesterase activity. The diisopropyl fluorophos-
phate-treated membranes were then diluted to 2.5 mg protein/ml with
buffer I (20 mM MOPS, 400 mM NaCl, 50 mM KCI, I mM EDTA, I
mM EGTA, pH 7.4). The receptor was solubilized by adding 20%
recrystallized Na cholate to a final concentration of 2%, incubating at
4°C with stirring for 1 h, and then centrifuging in a rotor (model Ti5O;
Beckman Instruments, Fullerton, CA) at 1 10,000 g for 30 min. The
supernatant was placed in Spectrapor dialysis tubing (mol wt cutoff
12,000-14,000), and Sephadex G-200 was applied to the outside ofthe
tubing to concentrate the sample. The concentration procedure took
-48 h at 4°C with an initial volume of 14-15 ml and a final sample
volume typically 0.4-0.6 ml.
Data acquisition
The fluorine NMR experiments were performed on a spectrometer
(model XL-400; Varian, Sunnyvale, CA) using a proton probe tuned
to 376.105 MHz and a spectral width of 5400 Hz centered between the
two major peaks in the spectrum. Between 3,600 and 6,000 free induc-
tion decays were averaged in each case. All analysis was performed
using FELIX (Hare Research, Inc, Woodinville, WA) after transfer to a
Silicon Graphics 4D/220GTX computer. The time domain signal was
apodized with a matched exponential function. Samples consisted of
10-40 uM acetylcholine binding sites (as determined by a['251]Bgt
binding assays) and 200-250 AM F3-TED in a 20% D20 solution. Tri-
fluoroacetic anhydride at a concentration of 200 MiM was used as an
internal reference. When used, an excess concentration ofHPIP (typi-
cally 5-6 mM) was added to displace F3-TED from its binding sites.
Control experiments were also performed in the presence of 80 AM
aBgt.
RESULTS
Radioligand binding measurements
General considerations
Two distinct states of agonist affinity are apparent using
the simultaneous addition protocol and the prior addi-
tion protocol. As demonstrated previously (Weber et al.,
1975; Weiland et al., 1976, 1977), the affinity for ago-
nists increases on the time scale of seconds to minutes
after agonist addition. This state transition is indicative
of receptor desensitization in that the functional activa-
tion ofthe channel decreases in parallel with the increase
in affinity (Sine and Taylor, 1979). To a first approxi-
mation, data from equilibrium competition experiments
can be modeled as follows:
L + R =LR
(A)Ml[ K'
L + R' =LR'
where R is the resting, nondesensitized receptor, R' is the
desensitized receptor, L is the ligand,M is the allosteric
constant reflecting the ratio of R'IR, KL is the equilib-
rium dissociation constant of the ligand for the desensi-
tized state. This model has been used extensively for the
analysis of binding data (e.g., Sine and Taylor, 1979;
Weber et al., 1975; Weiland et al., 1976, 1977); however,
time-dependent shifts in receptor affinity occur on time
scales that cannot be resolved by this technique (Boyd
and Cohen, 1980; Dunn et al., 1980; Heidmann and
Changeux, 1980). The protection constant for the simul-
taneous addition protocol (Kpimul) provides an upper
limit of the affinity for the nondesensitized state (i.e.,
lower limit on the numerical value of KL) in that the
process of desensitization (accompanied by an increase
in affinity) is occurring during the measurement process.
The protection constant for the prior addition condition
(KPpr0) is related to the affinity for the desensitized state
(K'L) by the following relationship:
(2)nMKnor
K prior
I
- l
KL cannot be determined directly but will be greater
than or equal to K "mu' due to a time-dependent increase
in affinity. This means that the Kpfr/KL ratio is signifi-
cantly less than one for agents that bind preferentially to
R' and approximately equal to one for those that bind
nonselectively. In the case ofpotent cholinergic agonists,
the KPpr"0/KL ratio is small, reducing the equation to:
KL
'MKpnor
L =
+ M
(3)
M is -0.1 (Weiland et al., 1976) for Torpedo electro-
plaque and 0.017 for BC3H- cells (Sine and Taylor,
1979).
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FIGURE I The inhibition ofthe initial rate ofa 125I ] Bgt binding to the
nAChR from Torpedo electroplaque membranes by PIP and TED
compounds. Representative experiments are shown, and the points are
averages of duplicate determinations. For the prior addition condition
(A), membranes were incubated with the test compound for 5 min
before the addition of a[ 1251] Bgt. A small percentage of the receptors
was in the low affinity state as shown by the deviation from simple mass
action inhibition, particularly for FPIP. Shown is the fit to the high
affinity portion of the binding curve. Longer incubations converted
essentially all of the receptor population to the high affinity state. For
the simultaneous addition condition (B), the compound to be tested
was added to the membrane at the same time as a[ 1251I] Bgt, and the
initial rate of binding was measured. Binding was linear up to 30 s.
Data were normalized to binding in the absence of PIP and TED com-
pounds, and nonspecific binding was defined by incubation in the pres-
ence of 1 mM carbamylcholine. The solid lines were generated using
Eq. I with nH = 1.
Torpedo electroplaque
The ability of the PIP and TED compounds to inhibit
the binding ofa[ 125I ] Bgt to nAChR from Torpedo mem-
branes was measured under two different conditions. In
the simultaneous addition protocol, the PIP compounds
inhibit a[ 1251] Bgt binding 10- to 50-fold more potently
than the TED compounds (Fig. 1 B). The comparison
between the PIPs and TEDs changes dramatically in the
prior addition condition (Fig. 1 A). In this case, the dif-
ference in protection constants is more than three orders
of magnitude (Table 1). This difference is due almost
entirely to a large increase in apparent affinity of the
PIPs after desensitization (300-fold increase). This indi-
cates that the PIP compounds promote a transition to
the desensitized state with much greater efficacy than the
TED compounds. As discussed above, the affinity mea-
sured in the simultaneous addition protocol can be con-
sidered a maximum affinity for the nondesensitized
state. Since the ratio of protection constants (TEDK1mu1'/
PIPKImul) between the TED and PIP compounds di-
verges with desensitization, the ratio oftheir affinities for
R can also be considered an upper limit ofthe true ratio.
Given the large shift in affinity for the PIP compounds,
the affinity for R' can be estimated from Eq. 3 and is
given in Table 1. In the case ofthe TED compounds, the
minimal shift in affinity with time suggests that the
KPprir/KL ratio is significant and that the affinity for R'
would be lower than that estimated by Eq. 3. This sug-
gests that the TEDKiPIPK.K ratio is greater than the ratio
of the protection constants (TEDKprior/PIPKprior)
BC3H-1 cells
Similar experiments were performed on membranes
from BC3H-1 cells, and the results are shown in Fig. 2.
Again, the PIP compounds were more potent in the prior
addition experiment than in the simultaneous addition
assay, whereas the binding of the TED compounds was
similar under the two different conditions. The ratio of
the affinity of PIPs to TEDs was 10- to 40-fold in the
simultaneous addition condition. As reported previously
(Sine and Taylor, 1979), the shift in apparent affinity
with desensitization is considerably less in BC3H-1 cells
than is observed in Torpedo electroplaque. The PIP
compounds exhibited a 10- to 40-fold increase in appar-
ent affinity; however, the TED compounds exhibited lit-
tle change in apparent affinity. Given thatM is an order
of magnitude lower in BC3H- 1 cells than in Torpedo
electroplaque, the K'L for the PIP compounds are of the
same order of magnitude in BC3H- 1 cells as in Tor-
pedo electroplaque (see Table 1). Like Torpedo, the
TEDK imul /PIPK smu ratio is an upper limit of the TEDKL/
P'PKL ratio and the TEDKprior/PIPK pror ratio is a lower
limit of the TEDKPIPK' ratio.
Single channel recording
The single channel kinetics of BC3H- 1 acetylcholine re-
ceptors exhibit a considerable amount ofdetail. This has
been interpreted with some success both as four to eight
discrete states (Sine and Steinbach, 1986, 1987; Papke
and Oswald, 1989) and as a discrete diffusion process
involving a large number of energetically related states
but a small number of rate constants ("Diffusion
Model") (Oswald et al., 1991; Millhauser et al., 1992).
The purpose of this communication is to compare the
properties of four related agonists, and a detailed de-
scription of the kinetics of this complex system will not
be attempted. For this reason, we will consider first a
subset of the full kinetic scheme that is common both to
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TABLE 1 PIP and TED binding to nAChRs from BC3H-1 cells and Torpedo electroplaque
Torpedo BC3H-1
K p K p K Or/K slm KL K pnor Ksm K pnor/, imu K 'L
HPIP 0.08* 43 530 0.0075 1.5 60 41 0.024
F3-PIP 0.11 43 390 0.01 3.3 34 10 0.055
HTED 120 430 3.4 12 330 700 1.8 6.5
F3-TED 340 3,300 6.5 31 1,100 1,500 1.4 18
HTED/HPIP F3-TED/F3-PIP
Torpedo Kprior 1,560 3,090
Torpedo KsimUl 10 52
BC3H-1 Kpnor 266 323
BC3H-1 KVrmuire1.7 41
*Values are given ing,M and represent the average of two to three experiments.
the Diffusion Model (Millhauser et al., 1992) and mod-
els involving a smaller number of discrete states:
ki k2
R+L= RL +L= RL2
k_l I r aw 2 o a (B)
RL* RL*
In this scheme, R, RL, and RL2 are unliganded, singly
liganded, and doubly liganded closed states andRL* and
RL* are singly and doubly liganded open states. Two
exponentials (corresponding to the closure of singly li-
ganded and doubly liganded channels) would be pre-
dicted in the open dwell time distribution, and the ratio
between the two exponentials should vary with agonist
concentration. This has been observed with acetylcho-
line as the agonist in BC3H- 1 cells (Papke and Oswald,
1989), with the exponential having the longer time con-
stant corresponding to the doubly liganded openings.
The PIP compounds exhibit behavior similar to acetyl-
choline as shown in the two-dimensional dwell time dis-
tributions (Fig. 3). At concentrations below 1 ,uM, the
open dwell time distribution is dominated by an expo-
nential component with a time constant of< 1 ms. As the
concentration is increased, the percentage of the longer
component increases. The two-dimensional dwell time
distributions demonstrate that the shorter openings are
consistently correlated with long channel closures,
whereas the longer openings are correlated with the full
range of closed times. Using a burst terminator of 1 ms,
the burst lengths also exhibit two exponentials, with the
longer events comprising more of the distribution at
higher concentrations than at lower concentrations, in-
creasing to a plateau of - 85% (Fig. 4 A). The reason for
the plateau seen in Fig. 4 A is not apparent, as Model B
predicts 100% long bursts at high concentrations; how-
ever, similar results have been observed with acetylcho-
line for BC3H- 1 cells (Sine and Steinbach, 1987; Papke
and Oswald, 1989), for rat muscle cells (Colquhoun and
Sakmann, 1985), and for purified nAChR from Tor-
pedo electroplaque (Labarca et al., 1985). Because signif-
icant channel blockade is present at 100 ,uM and above,
measurements of open channel lifetime were restricted
to lower concentrations for the TED compounds, and
the lifetimes were 25-50% of that observed for the PIP
compounds. The percentage of long bursts (burst ter-
minator of 1 ms) increased with increasing concentra-
tion to 65-75%.
At low concentrations of agonist, the closed time dis-
tribution clearly exhibits an exponential component that
approaches the time resolution of the system as well as
additional components (Fig. 5). This rapid component
is consistent with dwells in the RL2 state, and the time
constant is equal to the reciprocal of A + k-2* It is not
dependent on the ligand concentration and is not signifi-
cantly different between the four agonists, having a time
constant of 0.04-0.07 ms. The number of closures
within bursts represented by transitions between RL2
and RL * determines the l/k 2 ratio. These measure-
ments cannot be made in the presence of rapid channel
blockade because the number of closures within a burst
can be increased (sometimes dramatically) due to the
association and dissociation ofthe agonist with a binding
site inside the channel. Nevertheless, at low concentra-
tions of agonist where channel blockade is not signifi-
cant, estimates of A and k 2 can be made (Table 2).
Again, the differences between the compounds are not
great.
At low agonist concentrations, one of the three eigen-
values ofthe closed state matrix is approximated by -k_,
(Colquhoun and Hawkes, 1981; Sine et al., 1990). Ifk
is of the same order of magnitude as d and k-2, then an
exponential component arising from k-1 would not be
easily distinguishable from A and kL2. On the other hand,
if k-, is significantly slower, then a discrete component
could be observed in the closed time distribution at low
concentrations. Such a component has been observed
for Torpedo nAChR (Sine et al., 1990) and has been
taken as evidence for negative cooperativity in the ago-
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FIGURE 2 The inhibition ofthe initial rate ofa[ 1251I]Bgt binding to the
nAChR from BC3H-l cell membranes by PIP and TED compounds.
Representative experiments are shown, and the points are averages of
duplicate determinations. For the prior addition condition (A), mem-
branes were incubated with the test compound for 30 min before the
addition of a[ 1251] Bgt. For the simultaneous addition condition (B),
the compound to be tested was added to the membrane at the same
time as a[ 1251 ] Bgt, and the initial rate ofbinding was measured. Bind-
ing was linear up to 60 s. Data were normalized to binding in the
absence of PIP and TED compounds, and nonspecific binding was
defined by incubation in the presence of I mM carbamylcholine.
nist binding steps (Jackson, 1988; Sine et al., 1990)
(note, however, that a sequential model of induced fit
binding without negative cooperativity is also consistent
with these results; Auerbach, 1992). Despite negative
cooperativity in the binding steps, overall channel acti-
vation would be positively cooperative due to the large
(3/a ratio. As shown in Fig. 5, a presumably exponential
component with a time constant of 1-2 ms (i.e., greater
than that ascribed to ,3 + k-2) is present in the closed
time distribution of HPIP and F3-PIP at 100 nM and 1
,uM. The component with approximately the same time
constant is less apparent for the TED compounds, possi-
bly because of the low levels of channel activation, but
can be detected at 10 pM. These results are not inconsis-
tent with a strong negative cooperativity in binding and
do not reveal a clear difference between the PIP and
TED compounds.
To estimate the remainder of the constants in this
scheme, the open and closed dwell time distributions
were fit simultaneously with Model B using maximum
likelihood analysis. Because Model B is incomplete in
the sense that desensitization and channel block, which
dominate the closed time distribution at high concentra-
tions, are not included, fits were performed with the low-
est concentration(s) that gave adequate channel activa-
tion ( 100 nM and 1 uM for HPIP, 1 uM for F3-PIP, and
10 pM for HTED and F3-TED). The estimates for the
remainder of the parameters are given in Table 2, and
examples ofthe fit ofthese parameters with Model B are
shown in Fig. 5. According to this scheme, the large dif-
ferences between the compounds are in the association
rates. With the large number of parameters that are in-
volved in such a fitting procedure, the exact values ofthe
calculated rate constants have to be interpreted with
some caution. In particular, the assumption is made that
most of the closed time events included in the analysis
are intervals between the closure of one channel and the
opening of that same channel. This is probably a good
assumption for the PIP compounds, particularly at 100
nM and 1 ,uM, because most of the events in the closed
time distribution correspond to closures within a cluster
of openings separated by long closed times. Thus, in the
case ofthe PIP compounds, clusters ofchannel openings
were clearly defined, and the combinatorial analysis as
described by Horn and Lange ( 1983) was directly appli-
cable. For this analysis, the events list was edited to in-
clude only clusters of openings, which effectively re-
moved events that have been ascribed to singly liganded
channels, so that Model B is used without the RL* state.
The results obtained (given in Table 2) are not dramati-
cally different from those obtained using the matrix ap-
proach. Because most of the closed time distribution of
the TED compounds consisted of intervals > 10 ms at
concentrations of 10 ,uM and less, many of the intervals
may represent the time between the closure ofone chan-
nel and the opening ofanother. For this reason, the asso-
ciation rate constants are probably overestimates of the
true rates. These results confirm that the TED com-
pounds are poorer agonists than the PIP compounds,
with the difference arising largely from the association
rate constants.
At high concentrations, the PIP and TED compounds
exhibit another important difference. This is illustrated
in the two-dimensional dwell time distributions shown
in Figure 3. The TED compounds are clearly potent
channel blockers as demonstrated by the fact that most
of the density is located in the lower left quadrant of the
plot, particularly at 1 mM (i.e., short closures are corre-
lated with short openings). As shown in Fig. 4 C, F3-PIP
produces significant channel blockade at 1 mM, whereas
very little channel blockade is observed for HPIP. The
"flickering" observed at high concentrations for the
TED compounds and F3-PIP is consistent with sequen-
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FIGURE 3 Two-dimensional dwell time histograms for the PIP and TED compounds at four concentrations of each compound. The histograms
were generated by incrementing the value along the z-axis in the appropriate logarithmic two-dimensional bin (x = closed time; y = open time). The
histograms are shown as normalized, interpolated gray-scale plots with the z axis representing the square root of the number of events in each bin
(increasing from black to white). Before interpolation, each histogram had 25 bins along the open time axis and 30 bins along the closed time axis.
Each bin of a square root-log open time distribution (Sigworth and Sine, 1987) can be generated from these data by VZ (row2). The closed time
distribution can be generated in an analogous fashion.
tial channel blockade (Neher and Steinbach, 1978) in
that the open time decreases and the burst time increases
with increasing concentration of the blocking com-
pound (Fig. 4). The increased open time within a burst
is not strictly consistent with sequential channel block-
ade. However, here both the agonist and the blocker are
the same molecule so that increasing the agonist concen-
tration increases the blocker concentration. Since we re-
quire concentrations on the order of 0. 1-1 mM to pro-
duce channel blockade, dwells in the closed states cannot
always be distinguished temporally from dwells in the
blocked state, which means that the open time per burst
will increase with concentration. The large increase in
the burst length for HPIP at 1 mM is probably a reflec-
tion of the high rate of association of HPIP at this con-
centration rather than a dramatic increase in channel
blockade.
'H and 19F NMR spectroscopy
As discussed previously (McGroddy and Oswald, 1992),
two sets of resonances of unequal intensity are observed
for each group of magnetically equivalent protons in the
molecule. This indicates that two energetically different
stable solution state structures exist on the NMR time
scale, each with a different orientation with respect to the
amide bond. All of the minor conformer proton reso-
nances are deshielded with respect to the major con-
former resonances except for the amide methyl reso-
nances, which have the opposite orientation. This is due
to their positions with respect to the anisotropic carbonyl
oxygen. Previous work (McGroddy and Oswald, 1992)
demonstrated that the major solution conformer of the
TED compounds exists with the carbonyl oxygen trans
to the amide methyl protons and constrained near the
quaternary amine methyl groups due to electrostatic at-
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FIGURE 4 Characteristics of the open channel behavior of BC3H-I nAChRs activated by PIP and TED compounds. (A) Burst durations were
calculated with a burst terminator of 1 ms and fit to a double exponential distribution. The fraction ofevents represented by the exponential with the
longer time constant is plotted as a function of agonist concentration. (B and C) The open channel durations (0, *), burst durations (0, *0), and
open time within a burst (A, ,) were fit to a double exponential distribution ( 1-ms burst terminator). The length ofthe longer component is plotted
as a function ofagonist concentration. (D) Examples ofopen channel events produced by the four agonists at 1 4M, 100 MM, and 1 mM. Downward
deflections represent channel openings.
traction. The carbonyl oxygen is cis to the amide methyl
protons in the minor conformer. The free energy of acti-
vation for interconversion between the two states at 300
K is 18.8 kcal/ mol, with the majority ofthe barrier attrib-
uted to enthalpy ( 17.5 kcal/mol). The equilibrium con-
stant for the two conformers is 4.41, which corresponds
to a free energy difference of 0.89 kcal/mol between the
two states. This difference is somewhat larger (6.13 and
1.09 kcal/mol) for HTED.
A '9F spectrum of235 ,uM F3-TED in D20 is shown in
Fig. 6. Two singlet peaks, corresponding to the trifluoro-
acetylmethyl substituents on F3-TED in two different
conformations, are observed. Their relative intensities,
chemical shifts, and linewidths are potentially sensitive
measures of an interaction with the nAChR. Fig. 7 A
shows a spectrum of 235 ,uM F3-TED in the presence of
22 ,uM nAChR. The chemical shift difference between
the two resonances is decreased from 338.6 Hz (0.902
ppm) to 330.8 Hz (0.880 ppm). This is primarily due to
a deshielding of the smaller resonance by 9.4 Hz (0.025
ppm), but is unlikely to be related to an interaction with
the nAChR as described below. In addition, although
both resonances are somewhat broadened in compari-
son to the D20 spectrum, the less intense cis F3-TED
peak is significantly broadened in comparison to both
the larger trans F3-TED peak and the reference trifluoro-
acetic anhydride peak, suggesting that the bound and
free forms of cis F3-TED are in intermediate exchange.
On the addition of 5.5 mM HPIP to the sample (Fig. 7
B), the broadening of the less-intense resonance disap-
peared without an effect on the linewidth of the other
resonance. The increase in linewidth due to exchange
was 2.3-5 Hz in the presence of 22 ,uM nAChR and -
Hz in the presence of9.3 ,uM nAChR. The chemical shift
difference between the two F3-TED peaks remained the
same. The experiment was repeated in the presence of80
,uM aBgt to block any specific interaction of F3-TED
with the nAChR. This spectrum is shown in Fig. 7 C.
The chemical shift difference between the two peaks was
essentially unchanged from either of the previous two
experiments, and no broadening of the small F3-TED
resonance was observed. The spectrum of the sample
containing aBgt remained unchanged on the addition of
an excess of HPIP (data not shown). These results are
consistent with a preferential interaction of the cis con-
former with the acetylcholine binding sites of the Tor-
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FIGURE 5 Characteristics of the closed time intervals of BC3H- I nAChRs activated by PIP and TED compounds. The distributions are shown as
square root-log plots (Sigworth and Sine, 1987) and the fit to three or four exponentials is shown (dashed line) as well as the fit to Model B using the
constants given in Table 2 generated by the matrix method (solid line). The individual exponential components that comprise the exponential fits
are shown as dotted lines.
pedo nAChR. The possibility exists, however, that the
trans conformer could be in slow exchange with a highly
immobilized bound species for which no resonance
would be detected due to a very large linewidth. If this
were the case, then the integral of the trans peak would
increase with the addition of excess HPIP by an amount
consistent with the number ofbinding sites in the prepa-
ration (i.e., 10%). Likewise, the ratio ofthe integral of
the trans peak to the cis peak should increase with the
addition of HPIP (i.e., since the cis peak is in interme-
diate exchange, its integral is not expected to change). In
all cases measured, the trans:cis ratio was essentially un-
changed (or even slightly decreased) on the addition of
HPIP (transHplp/cisHpIp:tranSNOHPIP/cisNSNoHPIP 0.97 ±
0.02). Although this negative evidence cannot com-
pletely rule out an interaction of the trans conformer
with the nAChR, the existence of an interaction of the
trans isomer with the nAChR is unlikely given these
data.
DISCUSSION
The interaction of two classes of compounds with
nAChRs from Torpedo nobiliana and BC3H- 1 cell mem-
branes has been studied. In all cases, the PIP compounds
were more potent than the TED molecules in binding to
and activating the nAChRs. A number of distinctions
between these two classes ofcompounds were apparent:
(a) the PIP compounds bound with 10-50-fold higher
affinity to "resting" nAChRs; (b) the PIP compounds
produced an affinity shift consistent with receptor desen-
sitization, whereas the TED compounds induced little
desensitization; (c) the single channel recording studies
suggest that the association rates of the PIP compounds
are significantly greater than the TED compounds; and
(d) the TED compounds exhibited channel blockade at
concentrations of 100 ,M and above, F3-PIP exhibited
channel blockade at 1 mM, and no significant channel
blockade was observed for HPIP.
The accompanying article (McGroddy and Oswald,
1992) demonstrates that both classes ofcompounds can
exist in two distinct and stable (on the NMR time scale)
solution structures related by an isomerization of the
amide bond. In the case of the PIP compounds, the two
isomers are identical because of the symmetry of the
compound, and they would be expected to have identi-
cal biological activities. On the other hand, because the
TED compounds are not symmetric, the two isomers are
not identical. In fact, proton NMR studies (McGroddy
and Oswald, 1992) demonstrated that the two isomers
were also energetically inequivalent, with the lower en-
ergy trans structure favored over the higher energy cis
structure by four- to sixfold. The NMR studies and en-
ergy minimization using the CHARMm force field indi-
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TABLE 2 Rate constants for channel activation
Parameters HPIP (1 AM) F3-PIP(1 AM) HTED (10 ,M) F3-TED (10 MM)
Exponential fitting
k, (s-') 780 380 850 760
k-2 (s-') 13,000 12,000 12,000 11,000
d (s-') 7,600 7,800 3,400 4,977
T, (ms)* 0.06 0.05 0.06 0.06
Matrix method*
k, (M-' s-') 1.2 x 108 6.3 x 107 8.8 x I05 3.3 x 106
k, (s-') 550 700 810 880
k2 (M-' s-') 1.0 X 108 4.4 x 107 l.l X 106 7.0 X 106
k-2 (s-') 11,000 12,000 10,000 12,000
d (s-') 9,000 7,800 6,500 5,000
a (s-') 91 210 340 491
o' (s-') 22 24 7 3
a'(s-') 4,000 3,500 5,100 6,300
Kapp (M)§ 2.3 x 10-6 5.0x 10-5 6.4 x 10-4 2.0 x 10-4
Combinatorial analysis1l
k, (M-' s-') 1.3 x 108 1.4 x 108
k ,(s- ) 1,186 360
k2 (M-' s-') 1.7 X 108 2.7 X 107
k-2 (s-') 7,800 6,500
d (s-') 15,000 12,000
a (s-') 160 220
* Value of the shortest time constant from a three or four exponential fit.
Model B was used.
§ The Kapp is determined from the saturation function for model B:
L I 11I+ L 1
y_ K, ([ K41 K2 K3]2-1+ I+-I +2- I +-I
K, K4 K2 K3
where K,=k ,/kl, K2= k2/k2, K3 =/al, and K4 a'/Il.
11 Model B was used except that singly liganded channel openings were omitted.
cate that the trans isomer favors a conformation in
which the positively charged quaternary amine interacts
electrostatically with the partially negative carbonyl oxy-
gen. Thus, assuming that the cyclic PIP compounds are
in a conformation favorable for binding to and activat-
ing the nAChR, the cis TED isomers would be capable of
readily assuming this conformation. On the other hand,
assumption of a conformation similar to PIP by trans
TED would require disruption of the electrostatic inter-
action between the quaternary amine and the carbonyl
oxygen. Assuming that the cis TED affinity is similar to
that of the PIP conformers, cis TED might be expected
to bind preferentially to the nAChR, and the composite
affinity of the TED compounds would be lower relative
to the PIP compounds by a factor of 1 + KL, where KL is
the ratio of the populations of trans TED to cis TED.
Studies ofthe interaction ofF3-TED with the Torpedo
nAChR were undertaken to determine if in fact cis F3-
TED bound preferentially. Fluorine NMR was used be-
cause the signal from F3-TED could be measured in the
absence of a background signal from the receptor, deter-
gent, and solvent. Since, in biological terms, NMR is a
relatively insensitive technique, a large number of free
induction decays had to be averaged to provide an ade-
quate signal-to-noise ratio. However, the linewidth of
the signal from cis F3-TED was clearly larger in the ab-
sence than in the presence of agents that occupy the ace-
tylcholine binding sites (HPIP and aBgt), whereas the
trans F3-TED resonance was unaffected by this treat-
ment. These results indicate that cis F3-TED is in inter-
mediate exchange between the bound and free forms of
the compound. Unfortunately, without knowledge of
the chemical shift ofthe bound form, we cannot estimate
the exchange kinetics. Nevertheless, we can conclude
that cis F3-TED interacts with nAChRs, whereas no evi-
dence for the binding of trans F3-TED could be detected.
The possibility exists that trans F3-TED interacts with
the nAChR with the bound and free forms in slow ex-
change. No bound peak was observed, although it may
have been undetectable due to severe line broadening as
a result of immobilization on the surface ofthe receptor.
Also, no change in the intensity of the trans resonance
was observed, supporting the notion that the trans form
does not interact with the nAChR. These experiments
could not have detected an interaction of F3-TED with
the binding site mediating channel blockade because
binding to this site is inhibited potently by detergents
(Heidmann et al., 1983). Also, similar studies using F3-
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ity. Binding to the "resting" form of AChRs cannot be
accurately estimated by these techniques, but since there
is a time-dependent increase in affinity, the affinity mea-
sured with the simultaneous addition ofthe agonist with
a[ 125I ] Bgt provides an upper limit on the affinity. Under
these conditions, the ratio ofthe PIP to TED affinities is
on the order of 10-50. Since the PIP compounds tend to
induce more of an affinity shift than the TED com-
pounds, the true ratios are <10-50, suggesting that the
largely unfavorable solution structure of TED com-
pounds determines to a large extent the initial difference
in affinity between the PIP and TED compounds. The
6 5.5 5
ppm from trifluoroacetic acid
FIGURE 6 The '9F spectrum of F3-TED in D20. F3-TED exists in two
solution structures on the NMR time scale, with the more stable trans
structure favored by a factor of4.4 over the less stable cis structure. The
structures shown are ball-and-stick representations generated using
Quanta (Polygen/Molecular Simulations, Inc.) and represent the min-
imum energy structures from an adiabatic map generated in vacuum
using CHARMm (Polygen/Molecular Simulations, Inc.).
PIP were not successful. The major reason for this is that
F3-PIP was not stable in the solutions used for the NMR
studies, degrading with a half time of -2 h. Also, it is
likely that F3-PIP binds more tightly to nAChRs such
that it would be in slow exchange with the free form of
the compound. If this were true, then the compound
could be immobilized in the binding site to the extent
that the resulting rotational correlation time would lead
to a signal too broad to detect.
Thus, the NMR studies indicate that cis TED is the
minor conformer and very likely binds preferentially to
nAChRs. The simplistic assumption that cis TED would
have the same affinity for the nAChR as PIP would sug-
gest that HPIP would have an affinity sevenfold greater
than HTED, and F3-PIP would have an affinity 5.4-fold
greater than F3-TED. Considering first the binding ex-
periments, previous results from a number of laborato-
ries have indicated that the nAChR undergoes a shift in
affinity for agonist, which at least in Torpedo electro-
plaque has two components: one on the subsecond time
scale and the other on the time scale of several minutes.
In both cases, the shift is to a higher affinity and is asso-
ciated with desensitization. The binding experiments pre-
sented here can only detect the affinity shift that occurs
in the seconds to minutes time scale. Nevertheless, a
clear distinction between the PIP and TED compounds
can be observed. The PIP compounds bind to the desen-
sitized AChR from both Torpedo and BC3H- 1 cells with
a 1,000-fold higher affinity than the TED compounds.
Clearly, the solution structure of the TED compounds
can play only a marginal role in this difference in affin-
B
6.4 6.2 6.0 5.8 5.6 5.4 5.2
ppm from trifluoroacetic anhydride
FIGURE 7 '9F NMR spectrum of F3-TED in the presence of solubi-
lized nAChR from Torpedo electroplaque. Shown are the spectra with
(A) solubilized nAChR, (B) solubilized nAChR with 5.5 mM HPIP,
and (C) solubilized nAChR with 80 ,uM aBgt. In A and C, the nAChR
concentration was 22 ,M and the F3-TED concentration was 235 MM.
In B, the nAChR concentration was 18.3 MM and the F3-TED concen-
tration was 196 ,uM. The lower concentration of the reagents in B was
due to a dilution on addition of HPIP.
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affinity shift observed for the PIP compounds in Tor-
pedo is somewhat larger than that observed for acetyl-
choline and is largely due to a lower apparent affinity in
the simultaneous addition experiments (Weiland and
Taylor, 1979).
The single channel recording experiments reveal addi-
tional complexities in the comparisons between the two
compounds. Qualitatively, the TED compounds require
10-100-fold higher concentrations to activate nAChR
channels than the PIP compounds and exhibit consider-
ably more channel blockade. The models (Models B and
C) used to analyze the data are clearly insufficient to
account for all of the complexities of the nAChR behav-
ior over a wide variation in agonist concentration. How-
ever, estimates of the rate constants can be made under
some conditions. At low concentrations, the constants in
Model B can be estimated. The dissociation rate con-
stants (k, and k2) and the opening rate (A) vary little
between the PIP and TED compounds. On the other
hand, the estimates of k, and k2 suggest that the PIP and
TED compounds differ mainly in association rate, the
difference being approximately two orders of magni-
tude. In addition, a two- to threefold difference in closing
rate (a) exists between the two classes of compounds,
and TED compounds exhibit channel blocking activity
at a lower concentration than PIP compounds.
Since the work of Beers and Reich (1970), consider-
able effort has been devoted to producing a "pharmaco-
phore" capable of describing the structural and elec-
tronic features necessary for agonist activity at nicotinic
acetylcholine receptors (e.g., Wasserman et al., 1979;
Sheridan et al., 1986; Spivak et al., 1989). The overall
structures of these models consist of a cationic center
(e.g., the quaternary amine) and a hydrogen bond accep-
tor (e.g., the carbonyl oxygen), with a distance of - 5.9
A between the quaternary nitrogen and the van der
Waals extension of the carbonyl oxygen. Additionally,
the N( +) C C-0 backbone of acetylcholine
is assumed to be in its GAUCHE (GAUCHE and
TRANS refer to the N(+) C- C-N or N(+)
C C 0 backbone of TED or acetylcholine; cis and
trans refer to the amide bond) conformation (Sheridan
et al., 1986). This has served as the basis for the synthesis
of a number of very potent acetylcholine analogues, in-
cluding the PIP derivatives used in the present study
(e.g., Waters et al., 1988; Spivak et al., 1989). Behling et
al. (1988), however, have suggested based on two-di-
mensional NMR experiments that the N (+) C
C-0 backbone of acetylcholine may be TRANS when
bound to the desensitized nAChR of Torpedo electro-
plaque, whereas the acetylcholine in free solution was in
the GAUCHE conformation. Comparisons between the
PIP and TED compounds seem to be contrary to this
conclusion. The TED compounds, which are capable of
assuming either the TRANS or GAUCHE N(+) C-
C N conformation, bind with lower affinities than the
PIP compounds that are purely GAUCHE and are re-
stricted from attaining a TRANS conformation. A con-
formational search in vacuum using CHARMm (Poly-
gen, Inc., Waltham, MA) has shown that the preferred
orientation of the N(+)-C-C-N backbone in
HTED is TRANS, regardless of the orientation about
the amide dihedral. The two GAUCHE forms are 2-3
kcal /mol higher in potential energy. In addition, only cis
TED in the GAUCHE form exhibits a distance between
the quaternary amine and carbonyl oxygen suitable for
binding to the AChR (6.0 A). This distance is consider-
ably longer for cis TED in the TRANS form (7.4 A) and
shorter for trans TED in both the GAUCHE (5.0 A) and
TRANS (4.7 A) forms. This could indicate that only a
very small percentage ofHTED and F3-TED in solution
is in the correct conformation to bind to the nAChR,
and that isomerization about two dihedral angles (amide
and N (+)- C- C N) must occur before binding.
An additional difference between the PIP and TED
compounds that may relate to the differences in binding
affinity and association rate is the degree of hydration.
Molecular dynamics simulations using CHARMm in
water (499 TIP3P water molecules) indicate that all
forms of HTED have an average of two to five more
water molecules in the primary solvation shell than
HPIP (McGroddy, K. A., unpublished results). De-
pending on how tightly the water molecules are bound,
HTED may require more energy for desolvation before
binding than HPIP, thus decreasing the affinity.
A number of studies using NMR spectroscopy (e.g.,
Ni et al., 1990; Wuthrich et al., 1991) and x-ray crystal-
lography (e.g., Van Duyne et al., 1991) have shown that
the bound structure of a ligand can vary considerably
from its solution structure. This may indicate that the
traditional notion of a lock and key complementarity of
receptor-ligand interactions is considerably too simple in
that the ligand may undergo a distortion to interact in an
optimal manner with the receptor site (Jorgensen,
1991), although the preferential binding of a solution
conformer similar to the structure in the bound state has
been suggested (Altschuh et al., 1992). Our results sug-
gest that the predominant conformation of the ligand in
solution may not bind preferentially to the receptor.
This is to some extent an unusual case in that the energy
barrier for interconversion between the two stable solu-
tion structures of the TED molecules is very high. Con-
sider the simplified mechanism shown below:
KLI
LI =_ L2
+ +
R R
KDI A r KL2 A r KD2
RL1 = RL2
where LI is the lower energy conformer ofthe ligand, R is
the receptor, KLI and KL2 are isomerization constants
(e.g., KLI = [L1]/[L2j ), and KDI and KD2 are equilib-
rium dissociation constants. According to microscopic
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reversibility, the relationship between KD1 and KD2 is
given by:
KL2KD2 = KDI K
If one assumes that RL2 is the optimal conformation
(i.e., lower energy) of the receptor-ligand complex, then
KL2 is <1. Since by definition, KL1 is > 1, then L2 would
bind preferentially since its affinity for the receptor
would necessarily be greater than that ofL1 (KD2 < KD1).
This suggests that the preferential binding ofone confor-
mation of ligand is a direct consequence of a preferred
bound conformation. Furthermore, the observation of a
bound state structure that differs from the major solu-
tion conformation could be a result either of preferential
binding of a small population of ligand in the preferred
conformation or of the distortion of the ligand to fit the
binding site.
In summary, experiments using NMR spectroscopy
suggest that only one ofthe two stable solution structures
of the acyclic TED compounds may interact with the
nAChR. The equilibrium that favors the inactive con-
former effectively decreases the concentration of active
TED available for interaction with the nAChR. A signifi-
cant portion of the difference in the initial affinity be-
tween the PIP and TED compounds can be ascribed to
this solution behavior of the TED compounds. How-
ever, the binding experiments at equilibrium and single
channel experiments demonstrate that additional factors
may be important. These may include an unfavorable
orientation of the N(+)- C-C-N backbone in so-
lution and a greater hydration of all conformers of
HTED relative to HPIP. These results illustrate the com-
plexities involved in comparing the action of agonists
with similar chemical structures and the importance of
considering the contribution of the unbound solution
structure to agonist affinity.
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